Results of survival analysis demonstrated that glioma patients with high BCL7A expression presented a higher percentage of OS than patients with low BCL7A expression in CGGA and TCGA (HR = 0.475 and 0.185, respectively, all p < 0.05, Fig. 3). Here, BCL7A is linked to central nervous system cancer.